Therapeutic responses to <i>Roseomonas mucosa</i> in atopic dermatitis may involve lipid-mediated TNF-related epithelial repair
Ian A. Myles, Carlo R. Castillo, Kent Barbian, Kishore Kanakabandi, Kimmo Virtaneva, Emily Fitzmeyer, Monica Paneru, Francisco Otaizo‐Carrasquero, Timothy G. Myers, Tovah E. Markowitz, Ian N. Moore, Xue Liu, Marc Ferrer, Yosuke Sakamachi, Stavros Garantziotis, Muthulekha Swamydas, Michail S. Lionakis, Erik D. Anderson, Noah Earland, Sundar Ganesan, Ashleigh A. Sun, Jenna Bergerson, Robert A. Silverman, Maureen Petersen, Craig Martens, Sandip K. Datta
Abstract
Roseomonas mucosa treatment in children with atopic dermatitis is associated with clinical improvements and potentially lipid-mediated TNF signaling.
Topics & Concepts
Atopic dermatitisMedicineTumor necrosis factor alphaImmunologyDermatology and Skin Diseases